Comfortable leader
4 companies value 84 bn revenue 31 bn margin 12.8% free cash flow 5.2 bn avg. score 4.7
HLN holds 54.0% of the group's value, 1.3x the runner-up · KVUE leads the industry without being the largest
| Rank | Ticker | Company | Share | Value | Revenue | Margin | FCF | 5 years | FCF/px | Yield | What it does · why it is here |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HLN | Haleon United Kingdom · score 6.3 | 54% | 45 bn | 15 bn | 14.7% | 3.1 bn | 6.8% | — | Over-the-counter medicines: Sensodyne, Advil and Centrum · Sensodyne, Advil and Centrum, spun off from GSK | |
| 2 | KVUE | Kenvue United States · score 6.8 | 43% | 36 bn | 15 bn | 10.8% | 1.9 bn | 5.3% | 4.4% | Personal care: Tylenol, Band-Aid, Neutrogena and Listerine · Tylenol, Band-Aid and Listerine: over-the-counter pharmacy brands | |
| 3 | PBH | Prestige Consumer Healthcare Inc. United States · score 4.9 | 3% | 2.4 bn | 1.1 bn | 15.6% | 0.2 bn | 10.0% | — | Over-the-counter medicines and personal care products, since 1996 · New York — revenue of $1.1bn | |
| 4 | CABR | Caring Brands, Inc. United States · score 0.7 | 0% | 0.0 bn | 0.0 bn | — | 0.0 bn | — | -18.2% | — | Over-the-counter consumer products and cosmetics · Florida |
Other industries in the same sector
- Sector overview
- Large-cap pharmaceuticals 9 companies
- Biotechnology 57 companies
- European pharmaceuticals 5 companies
- Lab tools and consumables 37 companies
- Health insurance and services 17 companies
- Medical devices 87 companies
- Specialty pharmaceuticals 77 companies
- Pharmaceutical distribution 7 companies
- Clinical-stage pharmaceuticals 251 companies
- Robotic surgery and advanced medtech 9 companies
- Hospitals 23 companies
- Emerging biotech 5 companies
and 22 industries more
- Molecular testing and advanced diagnostics 42 companies
- Vaccines and mRNA 14 companies
- Clinical-stage biotech 200 companies
- Generics and biosimilars 10 companies
- Animal health 7 companies
- Contract research (CRO) 10 companies
- Healthcare software 18 companies
- Rehabilitation and home care 15 companies
- Genomics and sequencing 9 companies
- Structural heart 8 companies
- Ophthalmology 12 companies
- Medical imaging and hospital equipment 16 companies
- Diagnostic labs 6 companies
- Medical and dental supply distribution 3 companies
- Diabetes monitoring 9 companies
- Pharmaceutical royalties 5 companies
- Respiratory and sleep therapy 9 companies
- Orthopedic implants 17 companies
- Dialysis 3 companies
- Telehealth and digital health 12 companies
- Dental 4 companies
- Medical and recreational cannabis 16 companies
What this is. A catalogue, not a guide. Every industry with stocks listed on the NYSE or NASDAQ, the companies contending for its leadership, what each one does according to its own annual report, and the balance sheet it filed with the SEC.
The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.
The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.